National Development and Reform Commission: Tariff impacts on U.S. chips, pharmaceuticals, and other fields affect global technological development and harm the common interests of humanity

The National Development and Reform Commission announced that on April 14, the U.S. government once again manipulated the rhetoric of "national security" and brazenly initiated a trade investigation into the import of pharmaceutical and semiconductor products, unabashedly paving the way for increased tariffs through public opinion and legal channels. The U.S. side wields the "tariff stick" to forcibly disrupt the global technology supply chain, undermining the mutually beneficial win-win situation; raising the threshold for international technological cooperation, impacting the open and shared environment; curbing the momentum of global technological progress, and harming the common interests of all humanity.

History shows that intervening in cooperation through tariffs will ultimately fall into a self-defeating vicious cycle. The U.S. government has resumed high-tariff protectionism, attempting to reconstruct the technology industry landscape through administrative means, which is likely to repeat historical mistakes, and the outcome will inevitably be failure. The U.S. government needs to return to a rational path, replacing closed suppression with open cooperation, and reshaping the global technology win-win situation through fair competition.

The Development and Reform Commission mentioned that according to statistics from the Semiconductor Industry Association (SIA), about 75% of global chip manufacturing capacity is concentrated in East Asia. If the U.S. insists on promoting localization alternatives, the world will incur over $1 trillion in additional upfront investments. The medical field is also unlikely to escape; the Pharmaceutical Research and Manufacturers of America (PhRMA) bluntly stated that rebuilding domestic production lines in the U.S. will not only take 5 to 10 years but will also bring an investment burden of up to $2 billion per factory